There are 22 Drug Development investors in the AngelBacked database, ranked below by portfolio size. The most active include Alain HORVAIS, Hadrien Bouchez and Thierry Laugel. Each profile lists portfolio companies, sector focus, check size, and contact details.
Chief Strategy & Marketing Officer, AKA
Investment Director
Managing Partner
Sign up to view contact details, LinkedIn profiles, and export investor data.
AngelBacked lists 22 angel investors and VCs who invest in Drug Development startups. The most active by portfolio size include Alain HORVAIS, Hadrien Bouchez, Thierry Laugel.
Ranked by number of portfolio companies, the most active Drug Development investors in the AngelBacked database are Alain HORVAIS, Hadrien Bouchez, Thierry Laugel. Each profile lists their portfolio, sector focus, and contact details.
Every Drug Development investor profile on AngelBacked includes a verified email address alongside their portfolio companies, sector focus, and firm. Paid plans unlock the contact details and CSV export.
Check sizes vary by stage: angel investors backing Drug Development startups typically write $25K–$100K, while Drug Development-focused VCs range from $500K to $5M+ for early-stage rounds. Filter the database by check size to match your raise.